Ameritas Advisory Services, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Advisory Services, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2022$46,614
+94.2%
41,620
+100.0%
0.00%
+100.0%
Q3 2022$24,000
-22.6%
20,8100.0%0.00%
-50.0%
Q2 2022$31,000
-35.4%
20,8100.0%0.00%0.0%
Q1 2022$48,000
-15.8%
20,8100.0%0.00%0.0%
Q4 2021$57,00020,8100.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders